Malleo Giuseppe, Lionetto Gabriella, Crippa Stefano, Qadan Motaz, Moser Giada, Belfiori Giulio, Scarpa Aldo, Schiavo-Lena Marco, Casciani Fabio, Mattiolo Paola, Paiella Salvatore, Esposito Alessandro, Luchini Claudio, Ferrone Cristina R, Lillemoe Keith D, Fernández-Del Castillo Carlos, Falconi Massimo, Salvia Roberto
Unit of Pancreatic Surgery, University of Verona Hospital Trust, Verona, Italy.
Pancreatic Surgery, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006322.
To investigate whether revision of pancreatic neck margin based on intraoperative frozen section analysis has oncologic value in post-neoadjuvant pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC).
The role of intraoperative neck margin revision has been controversial, with little information specific to post-neoadjuvant PD.
Patients who underwent post-neoadjuvant PD (2013-2019) for conventional PDAC with frozen section analysis of neck margin at three academic institutions were included. Overall survival (OS) and recurrence-free survival (RFS) were compared across three groups: complete resection achieved en-bloc (CR-EB), complete resection achieved non-en-bloc (CR-NEB), and incomplete resection (IR).
Among the 671 patients included, 524 (78.1%) underwent CR-EB, 119 (17.7%) CR-NEB and 28 (4.2%) IR. Patients undergoing CR-NEB and IR exhibited larger tumors and lower rates of RECIST response, requiring vascular resections more often. Likewise, CR-NEB and IR were associated with a worse pathological profile than CR-EB. The incidence of postoperative complications and access to adjuvant treatment were comparable among groups. A CR-EB was associated with the longest OS duration (34.3 mo). In patients with positive neck margin, obtaining a CR-NEB via re-excision was associated with a comparable OS relative to patients with an IR (26.9 vs. 27.1 mo, P=0.901). Similar results were observed for RFS. At multivariable analysis, neck margin status was not independently associated with survival and recurrence.
Conversion of an initially positive pancreatic neck margin by additional resection is not associated with oncologic benefits in post-neoadjuvant PD and cannot be routinely recommended.
探讨基于术中冰冻切片分析对胰腺颈部切缘进行修正,在新辅助治疗后胰十二指肠切除术(PD)治疗胰腺导管腺癌(PDAC)中是否具有肿瘤学价值。
术中颈部切缘修正的作用一直存在争议,关于新辅助治疗后PD的具体信息较少。
纳入在三个学术机构接受新辅助治疗后PD(2013 - 2019年)治疗传统PDAC且对颈部切缘进行冰冻切片分析的患者。比较三组患者的总生存期(OS)和无复发生存期(RFS):整块完整切除(CR-EB)、非整块完整切除(CR-NEB)和不完全切除(IR)。
在纳入的671例患者中,524例(78.1%)实现CR-EB,119例(17.7%)实现CR-NEB,28例(4.2%)为IR。接受CR-NEB和IR的患者肿瘤更大,RECIST反应率更低,更常需要进行血管切除。同样,与CR-EB相比,CR-NEB和IR的病理特征更差。各组术后并发症发生率和辅助治疗的可及性相当。CR-EB与最长的OS持续时间(34.3个月)相关。在颈部切缘阳性的患者中,通过再次切除获得CR-NEB与IR患者的OS相当(26.9个月对27.1个月,P = 0.901)。RFS也观察到类似结果。在多变量分析中,颈部切缘状态与生存和复发无独立相关性。
在新辅助治疗后PD中,通过额外切除将最初阳性的胰腺颈部切缘转为阴性与肿瘤学获益无关,不能常规推荐。